Safety profile of jak-inhibitors versus TNF-inhibitors in real-world clinical practice: data from a multicenter register
14/08/2023
B. Hernández-Cruz1 , C. Sánchez-Piedra2 , M. Freire González3 , N. Busquets4 , J. García-González5 , M. Moreno6 , J. M. Blanco7 , S. Manrique Arija8 , E. PerezPampín9 , F. Sánchez-Alonso2 , I. Castrejon10on behalf of BIOBADASER.
EULAR 2021
DOI: 10.1136/annrheumdis-2021-eular.2645
https://ard.bmj.com/content/80/Suppl_1/68.1